- GlobeNewswire•11 hours agoSunesis Announces Closing of Public Offerings and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2016-- Sunesis Pharmaceuticals, Inc. today announced the closing of its previously announced underwritten offerings of 5,675,825 shares of its common stock at a price ...
- Insider Monkey•6 days agoWhy Traders Are Watching Manhattan Associates, Meridian Bioscience, Puma Biotechnology, Tesla and More
With earnings season in full swing, volatility in the indices has trended a bit higher compared to that of previous weeks. Among the stocks that are showing considerable volatility in their own share prices this morning are Manhattan Associates, Inc. (NASDAQ:MANH), Meridian Bioscience, Inc. (NASDAQ:VIVO), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), and Puma Biotechnology Inc (NYSE:PBYI). We’ll take a look at […]
- GlobeNewswire•6 days ago
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2016-- Sunesis Pharmaceuticals, Inc. today announced the pricing of underwritten offerings of 4,935,500 shares of its common stock at a price of $3.85 per share, and ...
Sunesis Pharmaceuticals, Inc. (SNSS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Day's Range||3.96 - 4.15|
|52wk Range||2.64 - 6.30|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.38|
|Avg Vol (3m)||134,641|
|Dividend & Yield||N/A (N/A)|